Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by VENManon Jan 20, 2018 8:49pm
215 Views
Post# 27402279

RE:ACB will buy CMED!

RE:ACB will buy CMED!Lets consider the 20 day moving average of CMED and HIP after all that's what ACB looked at when they made the first offer. 20 Day Moving Average for CMED $25.11, 20 Day moving average for HIP $1.26. A 50% premium over the 20 moving average for CMED $37.67, for HIP $57.29. The problem ACB is going to have is to try and convince CMED/HIP that without ACB they can't get to a $2 Billion Market Cap or over $52 per share which CMED/HIP will think they can easily get there on there own.


Plus, here is the other problem for ACB the 38% Locked In Shareholders was the percentage used before the HIP Deal was completed. 38% represents 9.1 Million Shares but now you have to divide that ownership into 38 Million Shares because now HIP owns CMED also. This 38% ownership has been reduced to only 24% now that HIP is with CMED. ACB has 5% but again with the HIP deal going through the 38% plus 5% which was 43% has become 24% plus 5% or only 29%. Add to this also that BZ bought more shares and converted more options and you start to see how dificult this will be for ACB.Some ACB Shareholders don't think that CMED/HIP could ever be worth $2 Billion or $53 per share without ACB but long term Shareholders in CMED feel CMED could easily go to a $2 Billion Market Cap without the HIP and HIP Shareholders have proven that the Market Supports UP Cannabis in a big billion dollar way. ACB is not going to have an easy time getting this deal done. CMED/HIP will go to $52 easy without ACB so why take 3 for 1 or $33.84 per share using the 20 day moving average price of ACB at $11.28?  ACB may have to do at least 4 for 1 and then it's a maybe? ALL IMO!! DYODD!!
<< Previous
Bullboard Posts
Next >>